Literature DB >> 262176

Secondary hypertriglyceridemia and hyperlipoproteinemia in patients with primary asymptomatic gout.

H K Naito, A H Mackenzie.   

Abstract

We carefully selected 30 men with primary gout, rendered asymptomatic by therapy, to examine the frequency and type of hyperlipidemia and hyperlipoproteinemia, with the objective of determining whether serum uric acid, alcohol intake, liver function, kidney function, and (or) drugs were participating in the secondary lipid disorder. Sixty-one age- and sex-matched men were used as controls. About 73% of the gout patients had hypertriglyceridemia, 1.6-fold the frequency found in the control group. Types IV and IIb lipoprotein electrophoretic patterns were most prevalent in the gout group. Neither alcohol intake nor hyperuricemia, per se, seems to be the cause of the lipid and lipoprotein disorder and cannot be related to liver or kidney dysfunctions. Obesity was the major underlying factor associated with the lipidemia. The study suggests that diet and, possibly, defective clearance of triglycerides may be etiologic factors associated with the abnormal serum triacylglycerol (triglyceride) and lipoprotein concentrations in these individuals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 262176

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Effect of treatment on erythrocyte phosphoribosyl pyrophosphate synthetase and glutathione reductase activity in patients with primary gout.

Authors:  J Braven; T R Hardwell; P Hickling; M Whittaker
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

2.  Hyperlipoproteinaemia in primary gout: hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan.

Authors:  S Jiao; K Kameda; Y Matsuzawa; S Tarui
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

3.  A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout.

Authors:  G A Ferns; J Lanham; P Dieppe; D J Galton
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

4.  Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia.

Authors:  Y Moriwaki; T Yamamoto; S Takahashi; Z Tsutsumi; K Higashino
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.